Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: Chemical and immunological characterization

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 1, 2005, Pages 19-26

  Marti, Thomas ^a   Molberg, Øyvind ^b   Li, Qing ^a   Gray, Gary M ^a   Khosla, Chaitan ^a   Sollid, Ludvig M ^b  

^a Celiac Sprue Research Foundation   (United States)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLIADIN; GLUTEN; PROLYL ENDOPEPTIDASE; RECOMBINANT ENZYME; T LYMPHOCYTE ANTIGEN;

ADULT; ANIMAL TISSUE; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOGENICITY; IMMUNOSTIMULATION; LYMPHOCYTE CLONE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; RAT; T LYMPHOCYTE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, LIQUID; EPITOPES; EPITOPES, T-LYMPHOCYTE; GLIADIN; GLUTEN; HUMANS; MASS SPECTROMETRY; PEPTIDES; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES;

EID: 11844263978     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.073312     Document Type: Article

References (23)

1. Arentz-Hansen H, Körner R, Molberg Ø, Quarsten H, Vader W, Kooy YM, Lundin KEA, Koning F, Roepstorff P, Sollid LM, et al. (2000) The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191:603-612.
2. Arentz-Hansen H, McAdam SN, Molberg Ø, Fleckenstein B, Lundin KEA, Jørgensen TJD, Jung G, Roepstorff P, and Sollid LM (2002) Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123:803-809.
3. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, and Schuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature (Lond) Med 3:797-801.
4. Farrell RJ and Kelly CP (2002) Celiac sprue. New Engl J Med 346:180-188.
5. Green PHC and Jabri B (2003) Coeliac disease. Lancet 362:383-391.
6. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-999.
7. Hausch F, Shan L, Santiago NA, Gray GM, and Khosla C (2002) Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol 283:G996-G1003.
8. Maiuri L, Ciacci C, Ricciardelli I, Vacca L, Raia V, Auricchio S, Picard J, Osman M, Quaratino S, and Londei M (2003) Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362:30-37.
9. Mäki M, Mustalahti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, et al. (2003) Prevalence of Celiac disease among children in Finland. N Engl J Med 348:2517-2524.
10. Molberg Ø, Kett K, Scott H, Thorsby E, Sollid LM, and Lundin KEA (1997) Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 46:103-108.
11. Molberg Ø, McAdam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, et al. (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717.
12. Piper JL, Gray GM, and Khosla C (2002) High selectivity of human tissue transglutaminase for immunoactive gliadin peptides: implications for celiac sprue. Biochemistry 41:386-393.
13. Piper JL, Gray GM, and Khosla C (2004) Effect of prolyl endopeptidase on digestive-resistant gliadin peptides in vivo. J Pharmacol Exp Ther 311:213-219.
14. Shan L, Molberg Ø, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, and Khosla C (2002) Structural basis for gluten intolerance in celiac sprue. Science (Wash DC) 297:2275-2279.
15. Shan L, Marti T, Sollid LM, Gray GM, and Khosla C (2004) Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for Celiac Sprue. Biochem J 383:311-318.
16. Sjöström H, Lundin KE, Molberg Ø, Körner R, McAdam SN, Anthonsen D, Quarsten H, Noren O, Roepstorff P, Thorsby E, et al. (1998) Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 48:111-115.
17. Sollid LM (2002) Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2:647-655.
18. Tuckova L, Novotna J, Novak P, Flegelova Z, Kveton T, Jelinkova L, Zidek Z, Man P, and Tlaskalova-Hogenova H (2002) Activation of macrophages by gliadin fragments: isolation and characterization of active peptide. J Leukoc Biol 71:625-631.
19. Turecek F (2002) Mass spectrometry in coupling with affinity capture-release and isotope-coded affinity tags for quantitative protein analysis. J Mass Spectrom 37:1-14.
20. Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Peña S, Mearin L, Drijfhout JW, and Koning F (2002) The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122:1729-1737.
21. Vader W, Stepniak D, Kooy Y, Mearin L, Thompson A, van Rood JJ, Spaenji L, and Koning F (2003) The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 100:12390-12395.
22. van de Wal Y, Kooy YM, van Veelen PA, Peña SA, Mearin LM, Molberg Ø, Lundin KEA, Sollid LM, Mutis T, Benckhuijsen WE, et al. (1998) Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 95:10050-10054.
23. Wieser H, Seilmeier W, and Belitz D (1994) Quantitative determination of gliadin subgroups from different wheat cultivars. J Cereal Sci 19:149-155.